Acidic pH hyperpolarizes nasal potential difference

Pediatric Pulmonology

Volumn 41, Issue 2, 2006, Pages 151-157

  Uwaifo, Omotola ^a   Bamford, Penelope ^a   Zeitlin, Pamela L ^b   Blaisdell, Carol J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chloride channel; CLC 2; Cystic fibrosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMILORIDE; CHLORIDE CHANNEL; CYCLIC AMP AGONIST; CYCLIC AMP DERIVATIVE; GLUCONIC ACID; NUCLEOTIDE; PROTEIN CLC2; UNCLASSIFIED DRUG;

ACIDITY; ADULT; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; ION TRANSPORT; LUNG PERFUSION; MALE; NASAL POTENTIAL DIFFERENCE; NON INVASIVE MEASUREMENT; NORMAL HUMAN; NOSE SECRETION; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY DISTRESS; RESPIRATORY EPITHELIUM; STANDARDIZATION;

ACIDOSIS; ADULT; BLOTTING, WESTERN; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CHLORIDE CHANNELS; CYSTIC FIBROSIS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MEMBRANE POTENTIALS; MIDDLE AGED; NASAL MUCOSA; REFERENCE VALUES;

EID: 31544472608     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20328     Document Type: Article

References (24)

1. Quinton PM. Cystic-fibrosis-a disease in electrolyte transport. FASEB J 1990;4:2709-2717.
2. Gowen CW, Lawson EE, Gingras-Leatherman J, Gatzy JT, Boucher RC, Knowles MR. Increased nasal potential difference and amiloride sensitivity in neonates with cystic fibrosis. J Pediatr 1986;108:517-521.
3. Knowles M, Gatzy J, Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 1981;305:1489-1495.
4. Knowles MR, Olivier KN, Hohneker KW, Robinson J, Bennett WD, Boucher RC. Pharmacologic treatment of abnormal ion transport in the airway epithelium in cystic fibrosis. Chest [Suppl] 1995;107:71-76.
5. Gaillard EA, Shaw NJ, Wallace HL, Subhedar NV, Southern KW. Airway ion transport on the first postnatal day in infants delivered vaginally or by elective cesarean section. Pediatr Res 2003;54:58-63.
6. Gaillard EA, Shaw NJ, Subhedar NV, Wallace HL, Southern KW. Employing the nasal potential difference as a diagnostic test for cystic fibrosis in neonates: potential pitfalls. J Pediatr 2002;141:295-296.
7. Boyle MP, Diener-West M, Milgram L, Knowles M, Foy C, Zeitlin P, et al. A multicenter study of the effect of solution temperature on nasal potential difference measurements. Chest 2003;124:482-489.
8. Blaisdell CJ, Edmonds RD, Wang XT, Guggino S, Zeitlin PL. pH-regulated chloride secretion in fetal lung epithelia. Am J Physiol Lung Cell Mol Physiol 2000;278:1248-1255.
9. Schwiebert EM, Cid-Soto LP, Stafford D, Carter M, Blaisdell CJ, Zeitlin PL, et al. Analysis of ClC-2 channels as an alternative pathway for chloride conduction in cystic fibrosis airway cells. Proc Natl Acad Sci USA 1998;95:3879-3884.
10. Bernacki SH, Nelson AL, Abdullah L, Sheehan JK, Harris A, Davis CW, et al. Mucin gene expression during differentiation of human airway epithelia in vitro. Muc4 and muc5b are strongly induced. Am J Respir Cell Mol Biol 1999;20:595-604.
11. Murray CB, Morales MM, Flotte TR, McGrath-Morrow SA, Guggino WB, Zeitlin PL. CLC-2: a developmentally dependent chloride channel expressed in the fetal lung and down-regulated after birth. Am J Respir Cell Mol Biol 1995;12:597-604.
12. Knowles MR, Clarke LL, Boucher RC. Extracellular ATP and UTP induce chloride secretion in nasal epithelia of cystic fibrosis patients and normal subjects in vivo. Chest [Suppl] 1992;101:60-63.
13. Schuler D, Sermet-Gaudelus I, Wilschanski M, Ballmann M, Dechaux M, Edelman A, et al. Basic protocol for transepithelial nasal potential difference measurements. J Cyst Fibros [Suppl] 2004;3:151-155.
14. Standaert TA, Boitano L, Emerson J, Milgram LJ, Konstan MW, Hunter J, et al. Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials. Pediatr Pulmonol 2004;37:385-392.
15. Grubb BR, Vick RN, Boucher RC. Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl- secretion in nasal epithelia of CF mice. Am J Physiol 1994;266:1478-1483.
16. Zsembery A, Fortenberry JA, Liang L, Bebok Z, Tucker TA, Boyce AT, et al. Extracellular zinc and ATP restore chloride secretion across cystic fibrosis airway epithelia by triggering calcium entry. J Biol Chem 2004;279:10720-10729.
17. Ho LP, Samways JM, Porteous DJ, Dorin JR, Carothers A, Greening AP, et al. Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis. Eur Respir J 1997;10:2018-2022.
18. Thiemann A, Grunder S, Pusch M, Jentsch TJ. A chloride channel widely expressed in epithelial and non-epithelial cells. Nature 1992;356:57-60.
19. Jordt SE, Jentsch TJ. Molecular dissection of gating in the ClC-2 chloride channel. EMBO J 1997;16:1582-1592.
20. Blaisdell CJ, Howard TD, Stern A, Bamford P, Bleecker ER, Stine OC. CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity. BMC Med Genet 2004;5:26.
21. Malinowska DH, Sherry AM, Tewari KP, Cuppoletti J. Gastric parietal cell secretory membrane contains PKA- and acid-activated Kir2.1 K+ channels. Am J Physiol Cell Physiol 2004;286:495-506.
22. Kellenberger S, Schild L. Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure. Physiol Rev 2002;82:735-767.
23. Cuppoletti J, Tewari KP, Sherry AM, Kupert EY, Malinowska DH. ClC-2 Cl- channels in human lung epithelia: activation by arachidonic acid, amidation, and acid-activated omeprazole. Am J Physiol Cell Physiol 2001;281:46-54.
24. Cuppoletti J, Malinowska DH, Tewari KP, Li QJ, Sherry AM, Patchen ML, et al. SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. Am J Physiol Cell Physiol 2004;287:1173-1183.